Loading...
Loading...
Browse all stories on DeepNewz
VisitGoogle Launches AlphaFold 3, Expanding AI's Role in Drug Discovery
May 12, 2024, 04:10 PM
Google, in collaboration with Isomorphic Labs, has launched AlphaFold 3, an advanced AI model developed by Google DeepMind. This new version represents a significant step forward from its predecessor, AlphaFold 2, by expanding its capabilities to predict not only the 3D structures of proteins but also the interactions and structures of all biomolecules including DNA, RNA, and ligands. AlphaFold 3 is expected to revolutionize the field of drug discovery by providing detailed predictions of biomolecular structures, thereby enhancing the understanding of cellular mechanics and disease.
View original story
Markets
No • 50%
Yes • 50%
Official announcements from Google or Isomorphic Labs, or credible scientific publications
Yes • 50%
No • 50%
Scientific research papers, official statements from health organizations or Google
No • 50%
Yes • 50%
Official press releases from Google, Isomorphic Labs, or partnering pharmaceutical companies
RNA • 25%
Proteins • 25%
DNA • 25%
Ligands • 25%
Scientific journals, Google or Isomorphic Labs announcements
Infectious Diseases • 25%
Cancer • 25%
Neurodegenerative Diseases • 25%
Genetic Disorders • 25%
Medical journals, Google or health organization announcements
Academic Research • 34%
Pharmaceuticals • 33%
Biotechnology • 33%
Press releases from relevant sector organizations and Google